Marcus Schulz - Jan 18, 2023 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role
Chief Revenue Officer
Signature
/s/ Marcus Schulz
Stock symbol
BLFS
Transactions as of
Jan 18, 2023
Transactions value $
-$87,456
Form type
4
Date filed
1/20/2023, 06:23 PM
Previous filing
Jan 12, 2023
Next filing
Jan 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLFS Common Stock Sale -$75.1K -3K -6.25% $25.04 45K Jan 18, 2023 Direct F1, F2
transaction BLFS Common Stock Sale -$12.3K -538 -1.2% $22.93 44.4K Jan 19, 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.10, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.